This is a free preview. For full access
Monoclonal Antibody Production with Hybridomas
Description
Hybridoma technology makes monoclonal antibodies in large amounts. Monoclonal antibodies are antibodies that bind to just one antigenic determinant, or epitope. These antibodies are important in research, diagnostics, and disease therapy. The method was developed in 1975 by Georges Köhler and Cesar Milstein, and it received ...
Show More
Transcript
Hybridoma technology is used to mass-produce monoclonal antibodies that can only bind to a single epitope — part of an antigen that elicits an immune response.
The process starts with injecting a mouse with a target antigen and then harvesting its spleen after a few weeks to isolate antibody-producing B cells. These cells have a limited ...
Show More